These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4334309)

  • 1. Effects of vasopressin, water load and aminophylline on adenosine 3', 5'-phosphate in human urine.
    Takahashi K
    Kobe J Med Sci; 1971 Mar; 17(1):17-33. PubMed ID: 4334309
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal response to aminophylline in relation to hydration and exogenous vasopressin.
    Nechay BR
    J Pharmacol Exp Ther; 1971 Feb; 176(2):377-82. PubMed ID: 4328015
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus.
    Fichman MP; Brooker G
    J Clin Endocrinol Metab; 1972 Jul; 35(1):35-47. PubMed ID: 4338115
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of a defect in the formation of adenosine 3',5'-monophosphate in vasopressin-resistant diabetes insipidus.
    Bell NH; Clark CM; Avery S; Sinha T; Trygstad CW; Allen DO
    Pediatr Res; 1974 Apr; 8(4):223-30. PubMed ID: 4362729
    [No Abstract]   [Full Text] [Related]  

  • 6. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
    Ohzeki T; Igarashi T; Okamoto A
    J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of clofibrate on water metabolism in hypothalamic and ADH-resistant diabetes insipidus.
    László FA; Czakó L
    Acta Med Acad Sci Hung; 1973; 30(1):139-48. PubMed ID: 4784147
    [No Abstract]   [Full Text] [Related]  

  • 9. The renal prostaglandin system in central diabetes insipidus: effects of desamino-arginine vasopressin.
    Düsing R; Herrmann R; Kramer HJ
    Adv Prostaglandin Thromboxane Res; 1980; 7():1111-3. PubMed ID: 6245565
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of vasopressin and renal prostaglandins in the homozygous diabetes insipidus rat.
    Dunn MJ; Kinter LB; Beeuwkes R; Shier D; Greeley HP; Valtin H
    Adv Prostaglandin Thromboxane Res; 1980; 7():1009-13. PubMed ID: 7369014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extracellular cyclic nucleotides: occurrence, analysis and diagnostic significance (author's transl)].
    Gerbitz KD; Wieland OH
    Z Klin Chem Klin Biochem; 1973 Jun; 11(6):224-32. PubMed ID: 4356758
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital nephrogenic diabetes insipidus in a baby girl.
    Schreiner RL; Skafish PR; Anand SK; Northway JD
    Arch Dis Child; 1978 Nov; 53(11):906-8. PubMed ID: 215090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exogenous vasopressin and growth hormone on the growth of rats with hereditary hypothalamic diabetes insipidus.
    Sokol HW; Sise J
    Growth; 1973 Jun; 37(2):127-42. PubMed ID: 4743991
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral antidiabetic agents on diuresis in diabetes insipidus of the vasopressin-responsive and the nephrogenous types.
    László FA; Czakó L
    Acta Med Acad Sci Hung; 1971; 28(2):196-204. PubMed ID: 5148333
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
    Uttley WS; Atkinson B; Adams A; Shirling D
    J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of vasopressin to produce normal urine concentration in patients with diabetes insipidus.
    ALEXANDER CS; FILBIN DM; FRUCHTMAN SA
    J Lab Clin Med; 1959 Oct; 54():566-71. PubMed ID: 13792580
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic use of chlorpropamide antidiuresis in diabetes insipidus].
    Schneider D; Fleischmann J; Haase R
    Z Gesamte Inn Med; 1972 Jan; 27(1):31-5. PubMed ID: 4335601
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of age, renal disease, hypertension, diuretics, and calcium on the antidiuretic responses to suboptimal infusions of vasopressin.
    Lindeman RD; Lee TD; Yiengst MJ; Shock NW
    J Lab Clin Med; 1966 Aug; 68(2):206-23. PubMed ID: 5912596
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various aspects of water-salt metabolism in heart congestive failure].
    Condorelli M
    Atti Soc Ital Cardiol; 1966; 1():197-379. PubMed ID: 5988840
    [No Abstract]   [Full Text] [Related]  

  • 20. [Association of vasopressin-sensitive diabetes insipidus with hyperlipoproteinemia].
    Padrón RS; Amaro S; Hung S; Licea M
    Rev Clin Esp; 1981 Jan; 160(1):35-7. PubMed ID: 7209049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.